Dr. Rachel Yehuda has studied post-traumatic stress disorder in combat veterans for decades. In November, her team at the James J. Peters VA Medical Center, in conjunction with the Multidisciplinary Association for Psychedelic Studies (MAPS), began enrolling U.S. military veterans in a phase 2 clinical trial for MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD).


Previous articleNuminus Wellness Inc. Graduates to the OTCQX Best Market
Next articleNuminus Identified as a Licensed Psilocybin Supplier by Health Canada